|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: GLOBOÊN 2012 v1.0. Cancer Incidence and Mortality
Worldwide: IARC cancer base no. 11. 2016:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxNovember
12–2015
|
|
2
|
Fossella F, Pereira JR, von Pawel J,
Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna
A, Fidias P, et al: Randomized, multinational, phase III study of
docetaxel plus platinum combinations versus vinorelbine plus
cisplatin for advanced non-small-cell lung cancer: The TAX 326
study group. J Clin Oncol. 21:3016–3024. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mccarthy N: A surprising competitor. Nat
Rev Cancer. 14:732014. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park BJ and Rusch VW: Lung cancer workup
and stagingSellke FW, del Nido PJ and Swanson SJ: Surgery of the
chest. 7th ed. Philadelphia, PA: Elsevier; pp. 241–251. 2005
|
|
6
|
Andrade FM, Mourad OM and Judice LF: The
revised tumor-node-metastasis staging system for lung cancer:
Changes and perspectives. J Bras Pneumol. 36:617–620. 2010.(In
English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kucuk U, Pala EE, Sezer O, Cakir E, Bayol
U and Divrik RT: Significance of TNM staging, demographic and
histologic features in predicting the prognosis of renal cell
carcinoma. Acta Chir Belg. 115:202–207. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Costi R, Beggi F, Reggiani V, Riccò M,
Crafa P, Bersanelli M, Tartamella F, Violi V, Roncoroni L and Sarli
L: Lymph node ratio improves TNM and Astler-Coller's assessment of
colorectal cancer prognosis: An analysis of 761 node positive
cases. J Gastrointest Surg. 18:1824–1836. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Marquette D, Pichon E, Deschasse G,
Lemaire B, Lemarie E, Diot P and Marchand-Adam S: Lung cancer in
adults: Better prognosis of patients aged 45 and under related to
good condition and lower TNM stage (a comparative and retrospective
study). Presse Med. 41:e250–e256. 2012.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mantovani A: Cancer: Inflaming metastasis.
Nature. 457:36–37. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faria SS, Fernandes PJ Jr, Silva MJ, Lima
VC, Fontes W, Freitas-Junior R, Eterovic AK and Forget P: The
neutrophil-to-lymphocyte ratio: A narrative review.
Ecancermedicalscience. 10:7022016.PubMed/NCBI
|
|
12
|
Marchioni M, Primiceri G, Ingrosso M,
Filograna R, Castellan P, De Francesco P and Schips L: The clinical
use of the neutrophil to lymphocyte ratio (NLR) in urothelial
cancer: A systematic review. Clin Genitourin Cancer. 14:473–484.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yodying H, Matsuda A, Miyashita M,
Matsumoto S, Sakurazawa N, Yamada M and Uchida E: Prognostic
significance of neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in oncologic outcomes of esophageal
cancer: A systematic review and meta-analysis. Ann Surg Oncol.
23:646–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim JH, Lee JY, Kim HK, Lee JW, Jung SG,
Jung K, Kim SE, Moon W, Park MI and Park SJ: Prognostic
significance of the neutrophil-to-lymphocyte ratio and
platelet-to-lymphocyte ratio in patients with stage III and IV
colorectal cancer. World J Gastroenterol. 23:505–515. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sun X, Liu X, Liu J, Chen S, Xu D, Li W,
Zhan Y, Li Y, Chen Y and Zhou Z: Preoperative
neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in
predicting survival for patients with stage I–II gastric cancer.
Chin J Cancer. 35:572016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gu X, Gao X, Li X, Qi X, Ma M, Qin S, Yu
H, Sun S, Zhou D and Wang W: Prognostic significance of
neutrophil-to-lymphocyte ratio in prostate cancer: Evidence from
16,266 patients. Sci Rep. 6:220892016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Templeton AJ, McNamara MG, Šeruga B,
Vera-Badillo FE, Aneja P, Ocaña A, Leibowitz-Amit R, Sonpavde G,
Knox JJ, Tran B, et al: Prognostic role of neutrophil-to-lymphocyte
ratio in solid tumors: A systematic review and meta-analysis. J
Natl Cancer Inst. 106:dju1242014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Todoric J, Antonucci L and Karin M:
Targeting inflammation in cancer prevention and therapy. Cancer
Prev Res (Phila). 9:895–905. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qi Q, Zhuang L, Shen Y, Geng Y, Yu S, Chen
H, Liu L, Meng Z, Wang P and Chen Z: A novel systemic inflammation
response index (SIRI) for predicting the survival of patients with
pancreatic cancer after chemotherapy. Cancer. 122:2158–2167. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gong W, Yang S, Yang X and Guo F: Blood
preoperative neutrophil-to-lymphocyte ratio is correlated with TNM
stage in patients with papillary thyroid cancer. Clinics (Sao
Paulo). 71:311–314. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jia J, Zheng X, Chen Y, Wang L, Lin L, Ye
X, Chen Y, Chen D and Dettke M: Stage-dependent changes of
preoperative neutrophil to lymphocyte ratio and platelet to
lymphocyte ratio in colorectal cancer. Tumour Biol. 36:9319–9325.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Özgehan G, Kahramanca Ş, Kaya IO, Bilgen
K, Bostanci H, Güzel H, Küçükpinar T and Kargici H:
Neutrophil-lymphocyte ratio as a predictive factor for tumor
staging in colorectal cancer. Turk J Med Sci. 44:365–368. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shalapour S and Karin M: Immunity,
inflammation, and cancer: An eternal fight between good and evil. J
Clin Invest. 125:3347–3355. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bar-Ad V, Palmer J, Li L, Lai Y, Lu B,
Myers RE, Ye Z, Axelrod R, Johnson JM, Werner-Wasik M, et al:
Neutrophil to lymphocyte ratio associated with prognosis of lung
cancer. Clin Transl Oncol. 19:711–717. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang L, Liang D, Xu X, Jin J, Li S, Tian
G, Gao Z, Liu C and He Y: The prognostic value of neutrophil to
lymphocyte and platelet to lymphocyte ratios for patients with lung
cancer. Oncol Lett. 14:6449–6456. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marijon H, Bouyon A, Vignot S and Besse B:
Prognostic and predictive factors in lung cancer. Bull Cancer.
96:391–404. 2009.(In French). PubMed/NCBI
|
|
27
|
Haberkorn U and Schoenberg SO: Imaging of
lung cancer with CT, MRT and PET. Lung Cancer. 34 Suppl 3:S13–S23.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Quint LE: Staging non-small cell lung
cancer. Cancer Imaging. 7:148–159. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Foulkes WD, Knoppers BM and Turnbull C:
Population genetic testing for cancer susceptibility: Founder
mutations to genomes. Nat Rev Clin Oncol. 13:41–54. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Afghahi A and Kurian AW: The changing
landscape of genetic testing for inherited breast cancer
predisposition. Curr Treat Options Oncol. 18:272017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Semeniuk-Wojtas A, Lubas A, Stec R, Syrylo
T, Niemczyk S and Szczylik C: Neutrophil-to-lymphocyte ratio,
platelet-to-lymphocyte ratio, and C-reactive protein as new and
simple prognostic factors in patients with metastatic renal cell
cancer treated with tyrosine kinase inhibitors: A systemic review
and meta-analysis. Clin Genitourin Cancer. Feb 2–2018.(Epub ahead
of print). View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nikolić I, Kukulj S, Samaržija M, Jeleč V,
Žarak M, Orehovec B, Taradi I, Romić D, Kolak T and Patrlj L:
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio help
identify patients with lung cancer, but do not differentiate
between lung cancer subtypes. Croat Med J. 57:287–292. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kemal Y, Yucel I, Ekiz K, Demirag G,
Yilmaz B, Teker F and Ozdemir M: Elevated serum neutrophil to
lymphocyte and platelet to lymphocyte ratios could be useful in
lung cancer diagnosis. Asian Pac J Cancer Prev. 15:2651–2654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Celik O, Akand M, Keskin MZ, Yoldas M and
Ilbey YO: Preoperative neutrophil-to-lymphocyte ratio (NLR) may be
predictive of pathologic stage in patients with bladder cancer
larger than 3 cm. Eur Rev Med Pharmacol Sci. 20:652–656.
2016.PubMed/NCBI
|
|
35
|
Kim YW, Kim SK, Kim CS, Kim IY, Cho MY and
Kim NK: Association of serum and intratumoral cytokine profiles
with tumor stage and neutrophil lymphocyte ratio in colorectal
cancer. Anticancer Res. 34:3481–3487. 2014.PubMed/NCBI
|
|
36
|
Wang J, Jia Y, Wang N, Zhang X, Tan B,
Zhang G and Cheng Y: The clinical significance of
tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte
ratio in patients with resectable esophageal squamous cell
carcinoma. J Transl Med. 12:72014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu Z and Xu W, Cheng H, Shen W, Ying J,
Cheng F and Xu W: The prognostic role of the platelet-lymphocytes
ratio in gastric cancer: A meta-analysis. PLoS One.
11:e1637192016.
|
|
38
|
Wu G, Yao Y, Bai C, Zeng J, Shi D, Gu X,
Shi X and Song Y: Combination of platelet to lymphocyte ratio and
neutrophil to lymphocyte ratio is a useful prognostic factor in
advanced non-small cell lung cancer patients. Thorac Cancer.
6:275–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun H, Hu P, Du J and Wang X: Predictive
value of inflammatory indexes on the chemotherapeutic response in
patients with unresectable lung cancer: A retrospective study.
Oncol Lett. 15:4017–4025. 2018.PubMed/NCBI
|
|
40
|
Chae YK, Galvez C, Anker JF, Iams WT and
Bhave M: Cancer immunotherapy in a neglected population: The
current use and future of T-cell-mediated checkpoint inhibitors in
organ transplant patients. Cancer Treat Rev. 63:116–121. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Durgeau A, Virk Y, Corgnac S and
Mami-Chouaib F: Recent advances in targeting CD8 T-Cell immunity
for more effective cancer immunotherapy. Front Immunol. 9:142018.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu ES, Oduyebo T, Cobb LP, Cholakian D,
Kong X, Fader AN, Levinson KL, Tanner EJ III, Stone RL, Piotrowski
A, et al: Lymphopenia and its association with survival in patients
with locally advanced cervical cancer. Gynecol Oncol. 140:76–82.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hwang JE, Kim HN, Kim DE, Choi HJ, Jung
SH, Shim HJ, Bae WK, Hwang EC, Cho SH and Chung IJ: Prognostic
significance of a systemic inflammatory response in patients
receiving first-line palliative chemotherapy for recurred or
metastatic gastric cancer. BMC Cancer. 11:4892011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
van Es N, Sturk A, Middeldorp S and
Nieuwland R: Effects of cancer on platelets. Semin Oncol.
41:311–318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li N: Platelets in cancer metastasis: To
help the ‘villain’ to do evil. Int J Cancer. 138:2078–2087. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Templeton AJ, Ace O, McNamara MG,
Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A,
Tannock IF and Amir E: Prognostic role of platelet to lymphocyte
ratio in solid tumors: A systematic review and meta-analysis.
Cancer Epidemiol Biomarkers Prev. 23:1204–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
